Omeros Corporation
OMER
$3.13
Share price
-0.63%
Change (1 day)
-44.70%
Change (1 year)
Categories
P/S ratio for Omeros Corporation (OMER)
P/S ratio as of April 2024 (TTM): N/A
According to Omeros Corporation's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0. At the end of 2023 the company had a P/S ratio of N/A.
P/S ratio history for Omeros Corporation from 2009 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | N/A | |
| 2022 | N/A | |
| 2021 | N/A | -100% |
| 2020 | 11.9 | 74.73% |
| 2019 | 6.83 | -62.63% |
| 2018 | 18.3 | 27.05% |
| 2017 | 14.4 | 40.65% |
| 2016 | 10.2 | -76.91% |
| 2015 | 44.3 | -97.18% |
| 2014 | > 1000 | 633.64% |
| 2013 | 214 | 859.81% |
| 2012 | 22.3 | 14.33% |
| 2011 | 19.5 | -77.25% |
| 2010 | 85.8 | -17.08% |
| 2009 | 103 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 3.80 | N/A | 🇺🇸 USA |
 Pfizer PFE | 2.48 | N/A | 🇺🇸 USA |
 Genetic Technologies GENE | 0.6268 | N/A | 🇦🇺 Australia |
 Eterna Therapeutics ERNA | 146 | N/A | 🇺🇸 USA |